7G13
Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2H-pyran-5-carboxylic acid, i.e. SMILES S1C(=C(C2=NC(=NO2)C2CC2)C2=C1CCCC2)NC(=O)C1=C(COCC1)C(=O)O with IC50=0.119472 microM
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SLS BEAMLINE X10SA |
| Synchrotron site | SLS |
| Beamline | X10SA |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2012-06-04 |
| Detector | PSI PILATUS 6M |
| Wavelength(s) | 1.000000 |
| Spacegroup name | P 2 21 21 |
| Unit cell lengths | 32.141, 53.024, 72.169 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 42.730 - 1.150 |
| R-factor | 0.1599 |
| Rwork | 0.158 |
| R-free | 0.19810 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | inhouse model |
| RMSD bond length | 0.020 |
| RMSD bond angle | 2.283 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.7.0025) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 42.730 | 42.730 | 1.180 |
| High resolution limit [Å] | 1.150 | 5.140 | 1.150 |
| Rmerge | 0.093 | 0.031 | 1.376 |
| Rmeas | 0.117 | 0.034 | 1.506 |
| Total number of observations | 269199 | ||
| Number of reflections | 44200 | 595 | 3111 |
| <I/σ(I)> | 10.49 | 44.42 | 1.38 |
| Completeness [%] | 98.9 | 99.2 | 96 |
| Redundancy | 6.03 | 5.903 | 6.018 |
| CC(1/2) | 0.998 | 0.999 | 0.494 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7 | 293 | protein in 25mM Tris/HCl pH 7.5 100mM NaCl, see also PMID 27658368 |






